激肽釋放酶原(PK)單克隆抗體

該抗體是針對PK的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別PK。

免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學(xué)：5-20μg/mL;1:50-200
免疫細(xì)胞化學(xué)：5-20μg/mL;1:50-200
最佳稀釋倍數(shù)最終由用戶決定。

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。

雜志	參考文獻(xiàn)
Int J Immunopathol Pharmacol	Altered activities of kininase II, an angiotensin converting enzyme, prekallikrein, and nitric oxide in Kuwaiti patients with type 2 diabetes [PubMed: 25964383]
Thromb Res	Factor XII–mediated contact activation related to poor prognosis in disseminated intravascular coagulation [PubMed: 26706311]
Thrombosis Research	Factor XII-mediated contact activation related to poor prognosis in disseminated intravascular coaCavia (Guinea pig )lation [Pubmed:26706311]
Annals of Laboratory Medicine	The First Case of Congenital Prekallikrein Deficiency in Korea With a Novel Pathogenic Variant (c. 1198G> T) [Pubmed: 30430790]
J Cell Mol Med	Huaier shows anti?\cancer activities by inhibition of cell growth, migration and energy metabolism in lung cancer through PI3K/AKT/HIF?\1\|á pathway [33377619]
J Thromb Thrombolysis	Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors [Pubmed:34993714]

留言咨詢

編號	適用物種：Homo sapiens (Human，人)	應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPB801Hu01	激肽釋放酶原(PK)重組蛋白	Positive Control; Immunogen; SDS-PAGE; WB.
PAB801Hu01	激肽釋放酶原(PK)多克隆抗體	WB; IHC; ICC; IP.
MAB801Hu22	激肽釋放酶原(PK)單克隆抗體	WB; IHC; ICC; IP.
SEB801Hu	激肽釋放酶原(PK)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)	Enzyme-linked immunosorbent assay for Antigen Detection.
LMB801Hu	激肽釋放酶原(PK)等多因子檢測試劑盒(流式熒光發(fā)光法)	FLIA Kit for Antigen Detection.

亚洲AV成人片色在线观看高潮_亚洲精品成a人在线观看夫_日本久久久久久久久精品_亚洲精品无码成人在线观看